Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Cross-Sectoral Health Threats
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2025 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Cross-Sectoral Health Threats
          3. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. IMEDS
          3. Post Market Research
          4. RAISE
          5. Real World Data
          6. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2025 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

Athersys, Inc.

By abhat@reaganud… on Wed, 04/01/2020 - 14:37
  • Read more about Athersys, Inc.

Ascletis Pharma Inc.

By abhat@reaganud… on Wed, 04/01/2020 - 14:30
  • Read more about Ascletis Pharma Inc.

Fujifilm Toyama Chemical Co. Ltd.

By abhat@reaganud… on Wed, 04/01/2020 - 14:05
  • Read more about Fujifilm Toyama Chemical Co. Ltd.

Eusa Pharma

By abhat@reaganud… on Wed, 04/01/2020 - 14:00
  • Read more about Eusa Pharma

I-Mab Biopharma Co. Ltd.

By abhat@reaganud… on Wed, 04/01/2020 - 13:47
  • Read more about I-Mab Biopharma Co. Ltd.

Roivant Sciences

By abhat@reaganud… on Wed, 04/01/2020 - 13:42
  • Read more about Roivant Sciences

Regeneron

By abhat@reaganud… on Wed, 04/01/2020 - 13:30
  • Read more about Regeneron

CytoDyn, Inc.

By abhat@reaganud… on Wed, 04/01/2020 - 13:16
  • Read more about CytoDyn, Inc.

Roche

By abhat@reaganud… on Wed, 04/01/2020 - 12:54
  • Read more about Roche

Reagan-Udall Foundation for the FDA Names Susan Winckler as CEO

The Reagan-Udall Foundation for the Food and Drug Administration has named Susan C. Winckler, RPh, Esq., former FDA Chief of Staff, as its Chief Executive Officer. She will assume the role on May 1, 2020.

Announcements
  • Read more about Reagan-Udall Foundation for the FDA Names Susan Winckler as CEO

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 284
  • Page 285
  • Page 286
  • Page 287
  • Current page 288
  • Page 289
  • Page 290
  • Page 291
  • Page 292
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA